MSC – Page 6 – Communicable Diseases Research

Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol

Covid-19에 대한 치료 중재로서의 중간 엽 기질 세포 : 살아있는 체계적인 검토 및 메타 분석 프로토콜

Protocol

Published on 2021-09-152022-08-31
Journal: Systematic Reviews [Category] COVID-19, meta-analysis, SARS,

[키워드] activated acute respiratory distress syndrome adverse event adverse events ARDS benefit Case series characterization Clinical outcome clinical study Community concerning conditioned media Controlled controlled trials Coronavirus disease 2019 COVID-19 CRD data extraction database determine Efficacy Evidence Exosomes extracellular vesicle Extracellular vesicles global pandemic Health Health policy immune response immune responses immunomodulatory information Isolation Laboratory lack life-threatening Mesenchymal stem cells Mesenchymal stromal cell Mesenchymal stromal cells meta-analyses Meta-analysis Microvesicles Mild MSC MSCs non-randomized outcomes pandemic Patient patient population performed Pneumonia populations protocol random-effect random-effects Random-effects meta-analysis Randomized real time SARS-CoV-2 SARS-COV-2 infection secreted Secretome Sepsis severe acute respiratory syndrome coronavirus 2 stromal cells subsequent supplementary material systematic literature search systematic review therapeutic intervention tissue repair treat trials
[DOI] 10.1186/s13643-021-01803-5 PMC 바로가기 [Article Type] Protocol

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS

Comment

Published on 2021-09-092022-10-04
Journal: NPJ Regenerative Medicine [Category] 임상,

Mesenchymal stem cell therapy for severe COVID-19

Perspective

Published on 2021-09-082022-10-04
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 바이오마커, 임상, 치료제,

Current therapeutic strategies for respiratory diseases using mesenchymal stem cells

Review

Published on 2021-09-022022-10-30
Journal: MedComm [Category] COVID-19,

Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application

블레오마이신 유발 폐섬유증에 대한 간엽줄기세포의 유효성: 체계적인 검토 및 임상적용 시사점

Review

Published on 2021-08-232022-09-10
Journal: Stem Cell Research & Therapy [Category] MERS, 유전자 메커니즘,

[키워드] acute lung injury acute respiratory syndrome Bacterial Bleomycin cells clinical clinical evidence Clinical research clinical trial clinical trials collagen coronavirus disease Coronavirus disease 2019 Coronavirus infections COVID-19 Critically ill cytokine damaged disease effective Effectiveness endothelial epithelial cells expression Extracellular matrix Factors fibrosis growth Idiopathic pulmonary fibrosis IMPROVE inflammatory cell inflammatory cell infiltration Inflammatory cytokine Inflammatory response inhibiting interstitial interstitial disease IPF life lung Lung injury lung tissue Mesenchymal stem cells Middle East Middle East respiratory syndrome Migration MOST MSC MSCs paracrine Patient permeability poor prognosis potential mechanism preclinical studies preclinical study Prognosis pulmonary pulmonary fibrosis Quality of life reduce reducing Research respiratory SARS-CoV-2 SARS-COV-2 infection secretion Severe acute respiratory syndrome STEM stem cell stem cells Support systematic review therapeutic tissue repair transformation Treatment Trial viral-induced
[DOI] 10.1186/s13287-021-02551-y PMC 바로가기 [Article Type] Review

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

Review

Published on 2021-08-212022-10-29
Journal: Stem Cell Research & Therapy [Category] COVID-19,

[키워드] activities acute respiratory distress acute respiratory syndrome administration Autoimmune benefit cause caused Cell clinical study clinical trial combination therapies coronavirus disease Coronavirus-2 COVID-19 Cytokine storm degenerative Diseases dose Effect exacerbated exaggerated immune response Exosome Exosomes Extracellular Genetic immune response immunomodulation immunomodulatory Inflammatory mesenchymal stem cell Mesenchymal stromal cell Modification morbidity Mortality MSC MSCs novel offer paracrine pathophysiology Population regenerative resulting SARS-CoV-2 supplementary material syndrome the cytokine storm therapeutic potential Therapies therapy Treatment Vesicle virus with COVID-19
[DOI] 10.1186/s13287-021-02542-z PMC 바로가기 [Article Type] Review

Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy

Article

Published on 2021-08-042022-10-28
Journal: Stem cell reviews and reports [Category] COVID-19,

Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells

간엽줄기세포에 의한 염증성 사이토카인 폭풍의 조절

Review

Published on 2021-07-292022-09-12
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단,

Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives

Review

Published on 2021-07-222022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19,

Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction

Commentary

Published on 2021-07-152022-10-29
Journal: Stem Cell Research & Therapy [Category] COVID-19, SARS,